Ph.D., CEO, Epic Bio
Biography
Dr. Salzman is a leader with more than 30 years of experience in the pharmaceuticals industry. She began her career at GlaxoSmithKline (GSK), and as a member of the research and development executive team she was responsible for overseeing global clinical trials with over 30,000 enrolled patients. Following her time at GSK, Dr. Salzman served as the CEO of Cardiokine and saw the successful sale of the company. She then co-founded Annapurna, SAS, where she served as president and CEO before its merger with Avalanche Biotechnologies to become Adverum Biotechnologies. After serving as President and CEO of Adverum, she served as president and CEO of Ohana Biosciences, pioneering the industry’s first sperm biology platform. She then joined Epic Bio as CEO, where the company leverages the power of CRISPR to modulate gene expression and develop much needed therapies.
Dr. Salzman serves on several Boards and leads the Stop ALD Foundation.
Session Abstract – PMWC 2023 Silicon Valley
Track 1 - January 25 9.00 A.M.-4.15 P.M.
Track Co-Chairs:
Yael Weiss, Mahzi
Peter Marks, FDA
- Welcome and Opening by Track Chairs: Yael Weiss, Mahzi
- PMWC 2023 Luminary Award Ceremony
- Allyson Berent, Angelman Foundation
- Terry Pirovolakis, CureSPG50 - From Bench to Bedside - Biomarkers, Natural History Studies, Animal Models (PANEL)
Chair: Peter Marks, FDA (Allyson Berent, FAST)
- Emil Kakkis, Ultragenyx
- Alysson Muotri, UCSD
- Nasha Fitter, Invitae - Commercialization - Moving from Rare to Common (PANEL)
Chair: Matthew Patterson, Vor Bio
- Shankar Ramaswamy, Kriya
- Rahul Singhvi, Resilience
- Sarah Glass, Ultragenyx
- Andrew Lo, MIT
- Mark Harrison, University of British Colombia - Future Modalities (PANEL)
Chair: Shannon Muir, CIAPM
- Nadav Ahituv, UCSF
- Amber Salzman, Epic Bio
- Ben Oakes, Scribe Therapeutics - PMWC NCI Showcase
- Michael M. Binkley, OpenCell
- Cellular Rejuvenation Programming
- Hana El-Samad, UCSF - Bioethics & Ethical Implications in Cell and Gene Therapies
- Hank Greely, Stanford
- Patient Driven Therapies: The Challenges and Successes (PANEL)
Chair: Yael Weiss, Mahzi
- Terry Pirovolakis, CureSPG50
- Allyson Berent, Angelman Foundation
- PMWC Showcase - Peter Marinkovich, Stanford
